DJIA 16,677.90 216.58 1.32%
NASDAQ 4,452.79 69.95 1.60%
S&P 500 1,950.82 23.71 1.23%
market minute promo

Pfizer (NYSE: PFE)

28.60 0.30 (1.06%)

REAL-TIME: Last trade at

Extended Hours: $29.00 $0.40 (1.40%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

PFE $28.60 1.06%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.65
Previous Close $28.30
Daily Range $28.57 - $28.87
52-Week Range $27.51 - $32.96
Market Cap $181.3B
P/E Ratio 17.80
Dividend (Yield) $1.04 (3.7%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 30,739,764
Average Daily Volume 27,517,846
Current FY EPS $2.26

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings

British Pharma GlaxoSmithKline reported third-quarter earnings this morning. Here's what you need to know.

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Ford, UPS, Nasdaq earnings in focus

After Hours Most Active for Oct 22, 2014 : T, YELP, NWSA, NWS, PFE, BPL, NS, AAPL, HPQ, QQQ, MSFT,

After Hours Most Active for Oct 22, 2014 : T, YELP, NWSA, NWS, PFE, BPL, NS, AAPL, HPQ, QQQ, MSFT, TVIX

Third Point's Daniel Loeb Tells Amgen it's Time to Break up

Roche’s Cancer Drug Sales Continue To Grow, May Face Competition In Medium Term

MannKind Corporation's Investors Shouldn't Dance Around This Issue

It's not a good sign that MannKind's competitor can't IPO.

Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog

Can Valeant's Strong Q3 Entice Allergan?

Week Ahead Market Report: October 20, 2014

See More PFE News...

PFE's Top Competitors

PFE $28.60 (1.06%)
Current stock: PFE
JNJ $102.63 (1.39%)
Current stock: JNJ
ROG $56.52 (2.73%)
Current stock: ROG
GSK $45.36 (2.14%)
Current stock: GSK